These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10902556)

  • 21. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric characteristics of a new 125I brachytherapy source.
    Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of dose-rate constant for 103Pd seeds with air kerma strength calibration based upon a primary national standard.
    Nath R; Yue N; Shahnazi K; Bongiorni PJ
    Med Phys; 2000 Apr; 27(4):655-8. PubMed ID: 10798685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
    Iwata K; Yue NJ; Nath R
    Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
    Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
    Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Meli JA
    Med Phys; 1990; 17(6):1032-40. PubMed ID: 2280732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.
    Butler WM; Stewart RR; Merrick GS
    Med Phys; 2009 Mar; 36(3):776-87. PubMed ID: 19378738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy.
    Murphy MK; Piper RK; Greenwood LR; Mitch MG; Lamperti PJ; Seltzer SM; Bales MJ; Phillips MH
    Med Phys; 2004 Jun; 31(6):1529-38. PubMed ID: 15259657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study.
    Luxton G
    Med Phys; 1994 May; 21(5):631-41. PubMed ID: 7935197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed.
    Patel NS; Chiu-Tsao ST; Williamson JF; Fan P; Duckworth T; Shasha D; Harrison LB
    Med Phys; 2001 Aug; 28(8):1761-9. PubMed ID: 11548947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.